1. Institute of Clinical Medicine –Neurosurgery, University of Eastern Finland and Department of Neurosurgery, Kuopio University Hospital, Kuopio, Finland
2. UCB, Braine-l’Alleud, Belgium
3. Janssen Research & Development, A Division of Janssen Pharmaceutica NV, Beerse, Belgium
4. Janssen Research & Development, La Jolla, CA, USA
5. Reference Center for Biological Markers of Dementia (BIODEM), Institute Born-Bunge, University of Antwerp, Antwerp, Belgium
6. AC Immune SA, Lausanne, Switzerland
7. Institute of Clinical Medicine –Pathology, University of Eastern Finland and Department of Pathology, Kuopio University Hospital, Kuopio, Finland
8. Institute of Clinical Medicine –Neurology, University of Eastern Finland and Department of Neurology, Kuopio University Hospital, Kuopio, Finland
9. Department of Neurosciences, University of Helsinki, Helsinki, Finland and Department of Geriatrics, Helsinki University Hospital, Helsinki, Finland
10. Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland
11. Department of Neurology and Center for Neurosciences, UZ Brussel and Vrije Universiteit Brussel (VUB), Brussels, Belgium
12. Clinical Neurochemistry Laboratory, Sahlgrenska Academy Hospital, Mölndal, Sweden
13. Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden
14. UCL Institute of Neurology, Department of Neurodegenerative Disease, University College London, Queen Square, London, United Kingdom
15. UK Dementia Research Institute, London, United Kingdom